Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Other financing activities (2021 - 2024)

Historic Other financing activities for Generation Bio (GBIO) over the last 4 years, with Q4 2024 value amounting to $158000.0.

  • Generation Bio's Other financing activities fell 1173.18% to $158000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $405000.0, marking a year-over-year decrease of 2956.52%. This contributed to the annual value of $405000.0 for FY2024, which is 2582.42% down from last year.
  • Per Generation Bio's latest filing, its Other financing activities stood at $158000.0 for Q4 2024, which was down 1173.18% from $247000.0 recorded in Q2 2024.
  • In the past 5 years, Generation Bio's Other financing activities ranged from a high of $438000.0 in Q1 2021 and a low of $13000.0 during Q4 2021
  • Its 4-year average for Other financing activities is $219923.1, with a median of $247000.0 in 2024.
  • The largest annual percentage gain for Generation Bio's Other financing activities in the last 5 years was 184615.38% (2022), contrasted with its biggest fall of 9617.35% (2022).
  • Quarter analysis of 4 years shows Generation Bio's Other financing activities stood at $13000.0 in 2021, then soared by 1846.15% to $253000.0 in 2022, then decreased by 29.25% to $179000.0 in 2023, then decreased by 11.73% to $158000.0 in 2024.
  • Its Other financing activities was $158000.0 in Q4 2024, compared to $247000.0 in Q2 2024 and $179000.0 in Q4 2023.